Newsletter | July 23, 2026

07.23.26 -- Solving Glycoengineering Challenges Could Begin At The Cell Line

INDUSTRY INSIGHTS

Automated Aseptic Sampling For Upstream Bioprocessing

Explore PAT, the use of automated sampling technology to accelerate analytical and quality control methods, the benefits of automated sampling in upstream process development, and more.

FEATURED EDITORIAL

Solving Glycoengineering Challenges Could Begin At The Cell Line

Researchers produced a panel of platform cell lines illustrating how glycoform selection can be made experimentally visible earlier in biologics development.

What Biopharma Often Overlooks In A Scheduled Shutdown

Shutting down an operating biologics facility upsets systems often designed for continuous operation. One expert shares his tips for preventing unnecessary problems.

Achieving Annex 1 Compliance In Sterile Manufacturing: Common Failures

A persistent gap remains between what Annex 1 requires and what facilities can demonstrate. Let's take a closer look at four common compliance failures.